# Nuclide record f-bone-targeted (section). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/fronts/f-bone-targeted/>
  a schema:DefinedTerm ;
  nuclide:kind "section" ;
  schema:identifier "f-bone-targeted" ;
  schema:name "Bone-targeted radiopharmaceuticals"@en ;
  schema:description "Some radioactive drugs are built to home in on damaged bone rather than the tumour itself, easing bone pain from cancer that has spread to the skeleton and, in one case, helping patients live longer."@en ;
  schema:url <https://nuclide.cc/fronts/f-bone-targeted/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.nejm.org/doi/10.1056/NEJMoa1213755>, <https://oncodaily.com/genitourinary-oncology/radical-2>, <https://pubmed.ncbi.nlm.nih.gov/41412927/>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC11544963/> ;
  nuclide:related <https://nuclide.cc/fronts/f-alpha-therapy/>, <https://nuclide.cc/fronts/f-radioligand-therapy/>, <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/ra-223/>, <https://nuclide.cc/isotopes/sm-153/>, <https://nuclide.cc/isotopes/sr-89/>, <https://nuclide.cc/isotopes/p-32/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate-mcrpc/>, <https://nuclide.cc/indications/rcc/>, <https://nuclide.cc/terms/bone-metastases/> ;
  nuclide:technologies <https://nuclide.cc/technologies/spect/> ;
  nuclide:drugs <https://nuclide.cc/drugs/radium-223/>, <https://nuclide.cc/drugs/samarium-153-lexidronam/>, <https://nuclide.cc/drugs/phosphorus-32/> ;
  nuclide:companies <https://nuclide.cc/companies/bayer/> ;
  nuclide:terms <https://nuclide.cc/terms/bone-metastases/> ;
  nuclide:trials <https://nuclide.cc/trials/alsympca/> ;
  nuclide:keyPapers <https://nuclide.cc/key-papers/paper-alsympca-radium-223-nejm-2013/> .